Keywords: Biotechnology, Stock, Share Prices, IPOs, Personalized medicines, Burrill

US Biotech closed 2009 on an upswing, despite negative start, says Burrill

Article | 06 January 2010

Print This

The biotechnology industry closed its books on 2009, a year where the sector's stock values dipped dramatically during a turbulent opening ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in